GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lytix Biopharma AS (STU:6BG) » Definitions » Policyholder Funds

Lytix Biopharma AS (STU:6BG) Policyholder Funds


View and export this data going back to 2021. Start your Free Trial

What is Lytix Biopharma AS Policyholder Funds?

Policyholder Funds only applies to insurance companies.


Lytix Biopharma AS Business Description

Traded in Other Exchanges
Address
Sandakerveien 138, Oslo, NOR, 0484
Lytix Biopharma AS is a clinical-stage biotech company engaged in developing cancer immunotherapies aimed at activating the patient's immune system to fight cancer. Its products, LTX-401, and LTX-315 are in the pipeline.